BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12626080)

  • 1. Hormone replacement therapy counseling: prevalence and predictors.
    Laborde J; Foley ME
    J Womens Health (Larchmt); 2002 Nov; 11(9):805-11. PubMed ID: 12626080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician counseling on hormone replacement therapy and bone loss: do socioeconomic and racial characteristics of women influence counseling?
    Neuner JM; McCarthy EP; Davis RB; Phillips RS
    J Womens Health (Larchmt); 2003 Jun; 12(5):495-504. PubMed ID: 12869297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
    Vinker S; Kaplan B; Yaphe J; Cohen O; Shumla V; Shapira G; Shofty I; Kitai E
    Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and health behavior in postmenopausal polio survivors.
    Kalpakjian CZ; Riley BB; Quint EH; Tate DG
    Maturitas; 2004 Aug; 48(4):398-410. PubMed ID: 15283932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral symptoms at menopause--the role of hormone replacement therapy.
    Tarkkila L; Linna M; Tiitinen A; Lindqvist C; Meurman JH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Sep; 92(3):276-80. PubMed ID: 11552144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of health counseling practices in hospitals: the patient's perspective.
    Pineault R; Champagne F; Maheux B; Legault C; Paré M
    Am J Prev Med; 1989; 5(5):257-65. PubMed ID: 2789847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australian women seeking counseling have higher use of health services.
    Schofield M; Khan A
    Womens Health Issues; 2008; 18(5):399-405. PubMed ID: 18774457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
    Lucas R; Barros H
    Maturitas; 2007 Jul; 57(3):226-32. PubMed ID: 17293067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life prevalence of hormone replacement therapy and profile of users have not changed among women with self-reported menopause in the last two decades in Porto, Portugal.
    Lucas R; Barros H
    Climacteric; 2008 Feb; 11(1):26-31. PubMed ID: 18202962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.
    Rondanina G; Puntoni M; Severi G; Varricchio C; Zunino A; Feroce I; Bonanni B; Decensi A
    J Clin Oncol; 2008 Mar; 26(9):1537-43. PubMed ID: 18349406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997.
    Bakken K; Eggen AE; Lund E
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):850-6. PubMed ID: 15315597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicians and the prescription of hormone replacement therapy in Spain.
    Bermejo MJ; Pérez IR
    Health Policy; 2005 Jul; 73(1):58-65. PubMed ID: 15911057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy: a survey of Irish general practitioners.
    Fallon U; Kelleher C
    Ir Med J; 2000; 93(1):10-1, 14. PubMed ID: 10740365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with intention to use hormone replacement therapy among Thai middle-aged women.
    Burusanont M; Hadsall RS
    Maturitas; 2004 Mar; 47(3):219-27. PubMed ID: 15036492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval.
    Thunell L; Stadberg E; Milsom I; Mattsson LA
    Acta Obstet Gynecol Scand; 2005 Apr; 84(4):395-401. PubMed ID: 15762973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
    Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Marchbanks PA; Coates RJ; Norman SA; Weiss LK; Ursin G; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Spirtas R
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1175-81. PubMed ID: 14652277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Should I give you my smoking lecture now or later?" Characterizing emergency physician smoking discussions and cessation counseling.
    Vokes NI; Bailey JM; Rhodes KV
    Ann Emerg Med; 2006 Oct; 48(4):406-14, 414.e1-7. PubMed ID: 16997676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of the effect of selection bias on the association of hormone replacement therapy and breast cancer risk.
    Csizmadi I; Friedenreich CM; Bryant HE; Courneya KS
    Chronic Dis Can; 2005; 26(2-3):73-9. PubMed ID: 16251013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.